Development
GE HealthCare Technologies Inc.
GEHC
$71.62
$0.070.10%
NASDAQ
| 12/31/2023 | 09/30/2023 | ||||
|---|---|---|---|---|---|
| Revenue | 7.96% | 0.10% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 7.96% | 0.10% | |||
| Cost of Revenue | 5.65% | 0.35% | |||
| Gross Profit | 11.42% | -0.26% | |||
| SG&A Expenses | 13.08% | -9.57% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.63% | -1.42% | |||
| Operating Income | 15.40% | 9.55% | |||
| Income Before Tax | -4.25% | 11.58% | |||
| Income Tax Expenses | -22.80% | 82.48% | |||
| Earnings from Continuing Operations | 7.77% | -10.85% | |||
| Earnings from Discontinued Operations | 100.00% | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -85.71% | 53.33% | |||
| Net Income | 7.47% | -10.29% | |||
| EBIT | 15.40% | 9.55% | |||
| EBITDA | 11.72% | 7.38% | |||
| EPS Basic | 7.46% | -10.29% | |||
| Normalized Basic EPS | -11.00% | 17.55% | |||
| EPS Diluted | 7.15% | -9.75% | |||
| Normalized Diluted EPS | -11.00% | 17.54% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | -- | -- | |||